Michael Wittekind
Plus aucun poste en cours
Profil
Michael Wittekind worked as an Executive Director-Research at Amgen, Inc. from 2003 to 2007, an Associate Director at Bristol-Myers Squibb Pharmaceutical Research Institute, and a Chief Scientific Officer & Senior VP-Research at ContraFect Corp.
from 2014 to 2016.
He also worked as a Director-Process Development at Phylos, Inc. Dr. Wittekind holds a doctorate degree from the University of Wisconsin and a graduate degree from the University of Washington.
Anciens postes connus de Michael Wittekind
| Sociétés | Poste | Fin |
|---|---|---|
| CONTRAFECT CORPORATION | Directeur Technique/Scientifique/R&D | 01/10/2016 |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/11/2007 |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | - |
Phylos, Inc.
 Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Formation de Michael Wittekind
| University of Wisconsin | Doctorate Degree |
| University of Washington | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CONTRAFECT CORPORATION | Health Technology |
| AMGEN INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Phylos, Inc.
Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA. | Commercial Services |
| Bristol-Myers Squibb Pharmaceutical Research Institute |